308 related articles for article (PubMed ID: 10383063)
1. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology.
Corbett EL; Hay M; Churchyard GJ; Herselman P; Clayton T; Williams BG; Hayes R; Mulder D; De Cock KM
Int J Tuberc Lung Dis; 1999 Jun; 3(6):501-7. PubMed ID: 10383063
[TBL] [Abstract][Full Text] [Related]
2. The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners.
Corbett EL; Churchyard GJ; Hay M; Herselman P; Clayton T; Williams B; Hayes R; Mulder D; De Cock KM
Am J Respir Crit Care Med; 1999 Jul; 160(1):10-4. PubMed ID: 10390373
[TBL] [Abstract][Full Text] [Related]
3. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners.
Corbett EL; Blumberg L; Churchyard GJ; Moloi N; Mallory K; Clayton T; Williams BG; Chaisson RE; Hayes RJ; De Cock KM
Am J Respir Crit Care Med; 1999 Jul; 160(1):15-21. PubMed ID: 10390374
[TBL] [Abstract][Full Text] [Related]
4. HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners.
Corbett EL; Churchyard GJ; Clayton TC; Williams BG; Mulder D; Hayes RJ; De Cock KM
AIDS; 2000 Dec; 14(17):2759-68. PubMed ID: 11125895
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterial disease in South African gold miners in the era of HIV infection.
Churchyard GJ; Kleinschmidt I; Corbett EL; Mulder D; De Cock KM
Int J Tuberc Lung Dis; 1999 Sep; 3(9):791-8. PubMed ID: 10488887
[TBL] [Abstract][Full Text] [Related]
6. Clinical and radiological features of Mycobacterium kansasii and other NTM infections.
Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D
Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110
[TBL] [Abstract][Full Text] [Related]
7. Clinical Relevance of Nontuberculous Mycobacteria Isolated from Sputum in a Gold Mining Workforce in South Africa: An Observational, Clinical Study.
van Halsema CL; Chihota VN; Gey van Pittius NC; Fielding KL; Lewis JJ; van Helden PD; Churchyard GJ; Grant AD
Biomed Res Int; 2015; 2015():959107. PubMed ID: 26180817
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterisation of clinical and environmental isolates of Mycobacterium kansasii isolates from South African gold mines.
Kwenda G; Churchyard GJ; Thorrold C; Heron I; Stevenson K; Duse AG; Marais E
J Water Health; 2015 Mar; 13(1):190-202. PubMed ID: 25719478
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study.
Corbett EL; Churchyard GJ; Clayton T; Herselman P; Williams B; Hayes R; Mulder D; De Cock KM
Am J Respir Crit Care Med; 1999 Jan; 159(1):94-9. PubMed ID: 9872824
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of 96 cases with pulmonary disease caused by nontuberculous mycobacteria].
Xia X; Gui X
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):239-41. PubMed ID: 11775923
[TBL] [Abstract][Full Text] [Related]
11. Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection.
Shitrit D; Peled N; Bishara J; Priess R; Pitlik S; Samra Z; Kramer MR
Respir Med; 2008 Nov; 102(11):1598-603. PubMed ID: 18619826
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for pulmonary disease due to culture-positive M. tuberculosis or nontuberculous mycobacteria in South African gold miners.
Sonnenberg P; Murray J; Glynn JR; Thomas RG; Godfrey-Faussett P; Shearer S
Eur Respir J; 2000 Feb; 15(2):291-6. PubMed ID: 10706494
[TBL] [Abstract][Full Text] [Related]
13. Variation in incidences of tuberculosis in subgroups of South African gold miners.
Kleinschmidt I; Churchyard G
Occup Environ Med; 1997 Sep; 54(9):636-41. PubMed ID: 9423575
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain].
Leal Arranz MV; Gaafar A; Unzaga Barañano MJ; Crespo Notario JA; Cisterna Cáncer R; García Cebrián F
Arch Bronconeumol; 2005 Apr; 41(4):189-96. PubMed ID: 15826528
[TBL] [Abstract][Full Text] [Related]
15. Non-tuberculous mycobacterial infections at San Francisco General Hospital.
Sheu LC; Tran TM; Jarlsberg LG; Marras TK; Daley CL; Nahid P
Clin Respir J; 2015 Oct; 9(4):436-42. PubMed ID: 24799125
[TBL] [Abstract][Full Text] [Related]
16. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study.
Bloch KC; Zwerling L; Pletcher MJ; Hahn JA; Gerberding JL; Ostroff SM; Vugia DJ; Reingold AL
Ann Intern Med; 1998 Nov; 129(9):698-704. PubMed ID: 9841601
[TBL] [Abstract][Full Text] [Related]
17. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the distribution of non-tuberculous mycobacteria strains isolated in National Tuberculosis Reference Laboratory in 2009-2010, Turkey].
Albayrak N; Simşek H; Sezen F; Arslantürk A; Tarhan G; Ceyhan I
Mikrobiyol Bul; 2012 Oct; 46(4):560-7. PubMed ID: 23188570
[TBL] [Abstract][Full Text] [Related]
19. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
Davies BS; Roberts CH; Kaul S; Klein JL; Milburn HJ
Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
[TBL] [Abstract][Full Text] [Related]
20. Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study.
Augustynowicz-Kopeć E; Siemion-Szcześniak I; Zabost A; Wyrostkiewicz D; Filipczak D; Oniszh K; Gawryluk D; Radzikowska E; Korzybski D; Szturmowicz M
Pol J Microbiol; 2019; 68(1):15-19. PubMed ID: 31050249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
